2003
Cardiac Resynchronization: A Brief Synopsis Part I: Patient Selection and Results from Clinical Trials
Kalinchak DM, Schoenfeld MH. Cardiac Resynchronization: A Brief Synopsis Part I: Patient Selection and Results from Clinical Trials. Journal Of Interventional Cardiac Electrophysiology 2003, 9: 155-161. PMID: 14574027, DOI: 10.1023/a:1026276205618.Peer-Reviewed Original ResearchConceptsHeart failureBiventricular pacingClass IV heart failureAcute hemodynamic benefitAcute hemodynamic parametersDepressed ejection fractionNYHA class IIISevere heart failureBundle branch blockLong-term functional capacityVentricular dysynchronyPrevious therapyVascular resistanceHemodynamic benefitsEjection fractionICD placementPatient selectionBranch blockMyocardial contractilityClinical trialsMechanical dysfunctionHemodynamic parametersMild symptomsSeparate indicationsFunctional capacitySustained hemodynamic benefit during long-term positive inotropic infusion in patients with advanced heart failure
Upadya S, Lee F, Saldarriaga C, Nystrom K, Katz S. Sustained hemodynamic benefit during long-term positive inotropic infusion in patients with advanced heart failure. Journal Of The American College Of Cardiology 2003, 41: 163-164. DOI: 10.1016/s0735-1097(03)81804-1.Peer-Reviewed Original Research
1987
Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis Pharmacokinetic-hemodynamic interactions
Blei A, Garcia-Tsao G, Groszmann R, Kahrilas P, Ganger D, Morse S, Fung H. Hemodynamic evaluation of isosorbide dinitrate in alcoholic cirrhosis Pharmacokinetic-hemodynamic interactions. Gastroenterology 1987, 93: 576-583. PMID: 3301517, DOI: 10.1016/0016-5085(87)90921-8.Peer-Reviewed Original ResearchConceptsIsosorbide dinitratePortal pressureArterial pressureHemodynamic changesHemodynamic evaluationHepatic vein wedge pressureHepatic venous gradientSystemic hemodynamic changesMean arterial pressureEffects of placeboValues 4 hStable cirrhoticsAlcoholic cirrhosisCardiac indexPortal hypertensionWedge pressureHemodynamic benefitsVenous gradientVasoactive metabolitesPharmacologic agentsIndividual patientsBaseline valuesExperimental animalsDinitratePatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply